Old Web
English
Sign In
Acemap
>
authorDetail
>
van Egmond, , H.M.
van Egmond, , H.M.
Immunology
Medicine
Stem cell
Transplantation
CD52
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Purified CD4 T-cell infusion can result in graft-versus-leukaemia without GVHD by recognition of broadly expressed minor histocompatibility antigens restricted by HLA class-II
2013
Van Balen P
van Bergen, , C.A.M.
I. Jedema
van Luxemburg-Heijs, , S.A.P.
Jessica C. Harskamp
van Egmond, , H.M.
Sabrina A.J. Veld
M. Griffioen
W.A.F. Marijt
C.J.M. Halkes
J.H.F. Falkenburg
Show All
Source
Cite
Save
Citations (0)
Alemtuzumab treatment can affect CD52 positive as well as CD52 negative GPI-deficient, Sezary
2011
Maarten H. Vermeer
van der Fits L
J. Jedema
van Egmond, , H.M.
J.H.F. Falkenburg
Constantijn J.M. Halkes
Show All
Source
Cite
Save
Citations (2)
T-cell chimerism does significantly bias overall chimerism status after T-cell depleted allogeneic stem cell transplantation and is influenced by immunological factors including the conditioning regimen, GvHD and CMV serostatus
2011
Jessica C. Harskamp
van der Heiden, , P.L.J.
van Egmond, , H.M.
Sabrina A.J. Veld
Hans L. Vos
Constantijn J.M. Halkes
Hendrik Veelken
J.H.F. Falkenburg
Erik W.A. Marijt
Show All
Source
Cite
Save
Citations (0)
Optimization of the HA-1-specific T-cell receptor for gene therapy of haematological malignancies after stem cell transplantation
2010
van Loenen, , M.M.
de Boer R
R.S. Hagedoorn
van Egmond, , H.M.
Avital L. Amir
R. Willemze
J.H.F. Falkenburg
M. H. M. Heemskerk
Show All
Source
Cite
Save
Citations (0)
1